Treatment with inhibitors against Src, EGFR, p38, PI3K, and Akt counteracted the radiation-induced MMP-2 upregulation and subsequently the invasion of mutant PTEN glioma cells in vitro [56]. The gene discussed is MAPK1; the disease is central nervous system cancer.